HOME >> BIOLOGY >> NEWS
Budding viral hijackers may co-opt cell machinery for the getaway

When retroviruses like HIV infect cells, they take over the cell's machinery to manufacture new copies of themselves. Research published this week in the top-tier open access journal, Journal of Biology, shows that to escape from cells, retroviruses may once again hijack cellular components, in this case molecules normally used to engulf material from the cell's surroundings in a pocket formed from cell membrane. The findings, offer new insights into how viruses propagate and cause disease, and how healthy cells work.

Retroviruses travel from cell to cell in 'spacecraft' surrounded by the membrane of host cells. These transporters protect the virus from attack by the immune system, as they disguise the virus as part of the body. The outer membrane of the virus particle also helps the virus to spread, as it can fuse with the membrane of other vulnerable cells.

During the construction of a virus particle, or virion, the cell membrane bulges outwards, engulfing viral components as it goes. One of the viral proteins, called Gag, is essential for this process.

Now, researchers from Columbia and Yale Universities, USA, Aijou University, South Korea and the Chinese Academy of Sciences has shown that some retroviral Gag proteins bind tightly to a host-cell protein called endophilin-2. Endophilin-2 is normally involved in the inward budding of the cell membrane, a process known as endocytosis.

Supporting the idea that this interaction is functionally relevant, the researchers found endophilin-2 inside viral particles that had budded from cells infected with Moloney-murine leukaemia virus. On further examination, they also found two other proteins involved in endocytosis, a-adaptin and clathrin, inside the virions. However, Dynamin-2, a protein that binds to endophilin-2, was not there. This suggests that the incorporation of selected proteins is unlikely to be accidental.

Endophilin-2's normal role is to increase the curvature of the
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-0-20-7323-0323
BioMed Central
3-Dec-2003


Page: 1 2

Related biology news :

1. Poetically Timed With Spring, Budding Yeast Yield Possible Insight Into Male Fertility--And Infertility
2. First glimpse of DNA binding to viral enzyme
3. X marks the spot: Vector insertion is viral specific
4. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
5. Researchers develop better understanding of immune response to viral infection
6. New papillomavirus target could lead to specific antiviral drugs for precancerous cervical lesions
7. Sick Kids researchers look at viral triggers for multiple sclerosis in children
8. The catch 22 of immune response to AIDs viral infection
9. A viral cure for type 1 diabetes
10. Purdue biologists expose the inner workings of viral machine
11. Retroviral protein triggers proliferation of immune cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... 05, 2020 , ... Regenative Labs has received approval from the Centers for ... them the first Wharton’s jelly allografts to be assigned a Q code and be ... the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P by ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... (PRWEB) , ... July 01, 2020 , ... ... presented its phase 1a findings of Neihulizumab, a biologic for the treatment of ... June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... cold chain validation engineering firm, is making available for free its new ... to incorporate concurrent transport simulation testing into today’s biologics licensing application (BLA). ...
(Date:7/31/2020)... ... 2020 , ... R3 Stem Cell International is now offering patients the opportunity ... cells total, patients may choose which extremities they would like treated. , Several studies ... Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the ... the history of eSource, the reasons it did not take off as quickly as ... source, the industry is moving towards capturing data electronically for clinical trials and then ...
(Date:7/18/2020)... ... , ... “We are thrilled to deliver this new technology to the industry” ... kind on the market and we were pleased that the IFT jury recognized that.” ... ingredients, creating a natural way to extend the shelf life and improve the safety ...
Breaking Biology Technology:
Cached News: